0001209191-19-007776.txt : 20190206 0001209191-19-007776.hdr.sgml : 20190206 20190206165135 ACCESSION NUMBER: 0001209191-19-007776 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190204 FILED AS OF DATE: 20190206 DATE AS OF CHANGE: 20190206 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sachdev Amit CENTRAL INDEX KEY: 0001406338 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 19572090 MAIL ADDRESS: STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED STREET 2: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-02-04 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001406338 Sachdev Amit C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 0 1 0 0 EVP, CRO Common Stock 2019-02-04 4 M 0 1942 86.52 A 48604 D Common Stock 2019-02-04 4 S 0 1200 186.57 D 47404 D Common Stock 2019-02-04 4 S 0 742 187.35 D 46662 D Common Stock 2019-02-04 4 M 0 2155 91.05 A 48817 D Common Stock 2019-02-04 4 S 0 1120 186.52 D 47697 D Common Stock 2019-02-04 4 S 0 1035 187.23 D 46662 D Common Stock 2019-02-04 4 S 0 5000 186.55 D 41662 D Common Stock 2019-02-04 4 S 0 3625 187.30 D 38037 D Common Stock 12215 I Held in Trust Common Stock 882 I 401(k) Stock Option (Right to Buy) 86.52 2019-02-04 4 M 0 1942 86.52 D 2027-02-02 Common Stock 1942 15533 D Stock Option (Right to Buy) 91.05 2019-02-04 4 M 0 2155 91.05 D 2026-02-01 Common Stock 2155 8622 D Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1. Open market sales reported on this line occurred at a weighted average price of $186.57 (range $185.99 to $186.90). Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $187.35 (range $187.03 to $187.59). Open market sales reported on this line occurred at a weighted average price of $186.52 (range $185.90 to $186.89). Open market sales reported on this line occurred at a weighted average price of $187.23 (range $186.94 to $187.60). Open market sales reported on this line occurred at a weighted average price of $186.55 (range $185.90 to $186.90). Open market sales reported on this line occurred at a weighted average price of $187.30 (range $186.92 to $187.63). The option vests in 16 quarterly installments from 2/3/2017. The option vests in 16 quarterly installments from 2/2/2016. /s/ Omar White, Attorney-in-Fact 2019-02-06